Dr. Gillespie is an evolutionary biologist with broad interests in organismal and molecular evolution. The major focus of his current research is deciphering the mechanisms by which obligate intracellular species of Rickettsiales (Alphaproteobacteria) invade, survive and replicate within eukaryotic cells.
In research funded by the National Institutes of Health, Dr. Gillespie utilizes phylogenetics, comparative genomics and bioinformatics to guide experimental research on various pathogenic species of Rickettsia and their associated arthropod vectors. His early research resulted in the reclassification of Rickettsia species and the identification of many lineage-specific pathogenicity factors. Through years of intense scrutinization of dozens of diverse rickettsial genomes, Dr. Gillespie and colleagues have described a large, dynamic mobilome for Rickettsia species, resulting in the identification of integrative conjugative elements as the vehicles for seeding Rickettsia genomes with many of the factors underlying obligate intracellular biology and pathogenesis. Via an iterative process of genome sequencing, phylogenomics, bioinformatics, and classical molecular biology and microbiology, Dr. Gillespie continues to lead and assist research projects on the characterization of rickettsial gene and protein function.
Co-founder and CSO of Celentyx Ltd.
Professor Emeritus of Cellular Immunology and Head of College of Medical and Dental Sciences Graduate School, University of Birmingham.
Raine Visiting Professor, University of Western Australia.
John Gordon is an internationally recognised authority on immune cell biology and immune cell-mediated diseases. For the past decade or so, John has been pioneering the field of Neuro-Immuno-Pharmacology. He is one of the world’s most highly cited researchers (www.ISIHighlyCited.com) and has a proven track record in the successful application of research within the field of translational medicine.
Gwyn is Professor of Cell Biology at the University of Glasgow where he has held a group leader position since 1989. He did his undergraduate and postgraduate work at the University of Southampton, studying lipid/protein interactions under the supervision of Tony Lee for his PhD. This was followed by postdoctoral work at Dartmouth Medical School where his interest in membrane trafficking began. His research focusses upon the control of glucose transport by insulin in adipocytes, muscle and cardiac tissue.
Previously the Chair of the Institute of Molecular Biology and Biochemistry, Medical University of Graz, Austria.
Expertise in Vascular Cell Biology, Intracellular Ion Mesaurements (e.g. Ca2+), Organelle Function (Mitochondria, ER), Live-cell Imaging, Confocal microscopy, Electrophysiology, Cell Physiology, Development of Biosensors, Signal Transduction,
Cell Biology, Energy metabolism, Aging.
- associate professor, Dept. of Genetics, Comenius University in Bratislava, Slovakia
- group leader, MFPL, Dept. of Chromosome Biology, University of Vienna, Vienna, Austria
- postdoctoral researcher, IMP (Research Institute of Molecular Pathology), Vienna, Austria (K. Nasmyth lab)
- postdoctoral researcher, Dept. of Zoology, Univ. of Oxford, Oxford, UK (S. Kearsey lab)
- PhD study, Dept.of Microbiology and Genetics, Univ. of Vienna, Vienna, Austria (R. Schweyen lab)
Professor of Genetics and is currently the Chair of the Institute of Life Sciences at the Hebrew University. Member of Faculty 1000 and has served on the editorial board of several journals.
Lamins and their associated proteins in health and disease The roles of the nuclear lamina in development and aging The role of the nuclear envelope in apoptosis Molecular and genetic analysis of matefin/SUN-1 The sensing and responding to high CO2 levels.
Professor of Internal Medicine and of Cell and Developmental Biology at University of Michigan Medical School. Fellow of the American Association for the Advancement of Science.
Emeritus Prof. of the Department of Zoology, University of Cambridge. Made a Fellow of the Royal Society in 1971, and knighted in 1995. He served as Master of Magdalene College, Cambridge, from 1995 to 2002. Awards include the 2012 Nobel Prize, the 1989 Wolf Prize in Medicine, the 2009 Albert Lasker Basic Medical Research award, the 1968 Scientific Medal of the Zoological Society, the 1987 Emperor Hirohito International Prize for Biology, & the 2001 Conklin Medal.
Max studied biochemistry and molecular biology in Argentina. In 2005, he was awarded a PhD in cell biology where he focused on the interactions between intracellular pathogens and the autophagic pathway. After that, he was in Gareth Griffiths Laboratory at EMBL, Heidelberg, Germany as a postdoctoral fellow of the von Humboldt foundation and EMBO focusing on the cell biology of macrophages and mycobacteria. In 2009, he became the head of the Junior Research Group “Phagosome Biology” at the Helmholtz Centre for Infection Research in Braunschweig, Germany. In 2012, he was recruited as a Programme Leader Track at the National Institute for Medical Research in London. Since 2015, he is a group leader at the Francis Crick Institute in London where he is developing imaging technologies and cellular models of infection to investigate the host-pathogen interactions in tuberculosis.
PhD in Neurobiology (UCL, UK), two post-docs in cellular neuroscience and stem cell biology (KCL, UK and Karolinska Institute, Sweden), appointed as a Neuroscience Lecturer at Imperial College London, UK and I have recently become one of its first Senior Teaching Fellows. For full information see my LinkedIn profile at https://www.linkedin.com/in/anitahall1 .
Associate Researcher in Center of System Biomedical Sciences, University of Shanghai for Science and Technology